Hospitals
Doctors
Treatment
About Us
The Company
The Partners
Services
Get Free Medical Advice
Home Blog healthcare Kaiser Permanente hospitals rated among nation’s best
July 16, 2024
No Comments

Kaiser Permanente hospitals rated among nation’s best

PRESS RELEASE
Contact: Vincent Staupe
[email protected]

OAKLAND, Calif. — Kaiser Permanente, the nation’s largest nonprofit, integrated health care provider, today announced that 37 of its hospitals received recognition from U.S. News & World Report in its annual hospital analysis.

U.S. News & World Report’s 2024–25 Best Hospitals report shows how well hospitals perform in 35 areas of care. Nearly 5,000 U.S. hospitals were evaluated.

According to the report:

In one or more areas of care, 37 Kaiser Permanente hospitals are “high performing.” High performers are among the top 10% to 20% of all hospitals rated.
The number of Kaiser Permanente hospitals that are “high performing” in specific categories are as follows:

Stroke treatment: 32
Heart failure treatment: 29
Kidney failure treatment: 16
Heart attack treatment: 16
Colon cancer surgery: 8

Nationwide, 4 Kaiser Permanente hospitals are in the top 50 for an area of specialty care:

The Kaiser Permanente Los Angeles Medical Center is 23rd in California for overall care and 40th nationwide for neurology and neurosurgery.
The Kaiser Permanente Vallejo Medical Center is 28th nationwide for rehabilitation services and treatment.
Kaiser Permanente’s Orange County–Anaheim and Orange County–Irvine medical centers are 47th in the nation for pulmonology and lung surgery.

At least one of Kaiser Permanente’s hospitals are nationally ranked or rated as “high performing” in these 8 specialty care areas:

Cardiology and heart surgery
Gastroenterology and gastrointestinal surgery
Geriatrics
Neurology and neurosurgery
Orthopedics
Pulmonology and lung surgery
Rehabilitation
Urology

High-quality, equitable care

For the first time, the U.S. News Best Hospitals report honored success in caring for patients in historically underserved communities. These patients often face many social and economic challenges in receiving health care.

Three Kaiser Permanente hospitals received the new recognition. Kaiser Permanente’s Fontana, Ontario and South Sacramento medical centers were on U.S. News’ list of Best Regional Hospitals for Equitable Access.

“This recognition reflects our dedication to providing quality care for all our members,” said Andrew Bindman, MD, executive vice president and chief medical officer at Kaiser Permanente. “Year after year, our strong quality rankings show the value of our unique model of health care.”

State rankings

Fourteen Kaiser Permanente hospitals in California ranked among the top 60 in the state for overall care:

Orange County–Anaheim Medical Center
Baldwin Park Medical Center
Fontana Medical Center
Orange County–Irvine Medical Center
Los Angeles Medical Center
Oakland Medical Center
Ontario Medical Center
Richmond Medical Center
Roseville Medical Center
San Diego Medical Center
San Francisco Medical Center
Santa Clara Medical Center
South Sacramento Medical Center
Zion Medical Center (in San Diego)

Kaiser Permanente’s Moanalua Medical Center in Honolulu ranked second in Hawaii while Kaiser Permanente’s Sunnyside Medical Center in Clackamas, Oregon, ranked fifth in the state.

“Our hospitals’ performance in their home states reflects the breadth of medical expertise across Kaiser Permanente’s footprint and the patient-centered care delivered by our multidisciplinary teams of doctors, nurses and other clinicians,” said Nancy Gin, MD, FACP, executive vice president of quality and chief quality officer for The Permanente Federation. “To be high performing in so many areas of advanced care and treatment highlights our specialty physicians and clinicians, who meet the care needs of our patients every day.”

In its hospital analysis, U.S. News uses measures such as risk-adjusted mortality rates, preventable complications, level of nursing care, expert opinion and patient experience. For more information, visit U.S. News & World Report.

About Kaiser Permanente

Kaiser Permanente is committed to helping shape the future of health care. We are recognized as one of America’s leading health care providers and not-for-profit health plans. Founded in 1945, Kaiser Permanente has a mission to provide high-quality, affordable health care services and to improve the health of our members and the communities we serve. We currently serve 12.5 million members in 8 states and the District of Columbia. Care for members and patients is focused on their total health and guided by their personal Permanente Medical Group physicians, specialists, and team of caregivers. Our expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, state-of-the-art care delivery, and world-class chronic disease management. Kaiser Permanente is dedicated to care innovations, clinical research, health education, and the support of community health.

Share on Facebook
Share on Twitter
healthcare

Add comment

Categories

brain 1 drug 1 healthcare 14 Uncategorized 37

Popular Posts

Promising lung cancer vaccine trial begins in UK
Promising lung cancer vaccine trial begins in UK
August 23, 2024
‘Our daughter should not have died from Covid jab’
‘Our daughter should not have died from Covid jab’
August 23, 2024
First drug to slow Alzheimer’s too costly for NHS
First drug to slow Alzheimer’s too costly for NHS
August 22, 2024

Tag Cloud

brain drug healthcare heathcare

Read More

Related Posts

Kaiser Permanente tops Colorado ‘Top Doctors’ list

Kaiser Permanente tops Colorado ‘Top Doctors’ list

August 21, 2024
A gap often exists between emerging technologies and their implementation. New technologies can improve our lives. But they can also change our lives. These changes may initially cause fear and anxiety. Emerging technology is especially complicated in health care. There are so many factors to consider, including patient preferences and federal regulations. At Kaiser Permanente, it’s our job to navigate these issues as we consider how new technologies might help us provide better care for our patients. Artificial intelligence is no exception. We believe our clinicians and care teams can use AI to improve health outcomes for our members and the communities we serve. But we also know that nothing slows down the adoption of new technologies more than lack of trust — or worse, technologies that can lead to patient harm. That’s why we use a responsible AI approach. This means we adopt AI tools and solutions only after we thoroughly assess them for excellence in quality, safety, reliability, and equity. With a focus on building trust, we use AI only when it advances our core mission of delivering high-quality, affordable health care services. Our principles for assessing responsible use So how do we assess and deploy AI tools to make sure they meet our standards? We start with privacy. AI tools require a vast amount of data. Ongoing monitoring, quality control, and safeguarding are necessary to protect the safety and privacy of our members and patients. We continually assess for reliability. What works today may not work a few years down the road as technology, care delivery, and patient preferences evolve. We choose AI tools that will work for the long term. We focus on outcomes. If an AI tool doesn’t advance high-quality and affordable care, we don’t use it. We strive to deploy tools transparently. We make patients aware of and ask for consent to our use of AI tools whenever appropriate. For our employees who use AI, we provide explanations of how our AI tools were developed, how they work, and what their limitations are. We promote equity. People and algorithms (the instructions that AI tools follow) alike can contribute to bias in AI tools. Our AI tools are built to minimize bias. We also know AI has the potential to harness large amounts of data and to help identify and address the root causes of health inequities. So, we are also focused on that potential. We design tools for our customers — in the case of AI, our customers are our members, doctors, and employees who will use the tools. Tools must prioritize their needs and preferences. We build trust. We know there’s uncertainty about the effectiveness of AI. We choose tools that offer excellence in safety and performance, and alignment with industry standards and leading practices. We further build confidence by continually monitoring the tools we use. We continue to invest in research that rigorously evaluates the impact of AI in clinical settings. Our principles in action: Assisted clinical documentation One example of how we’ve applied these principles is with our use of an assisted clinical documentation tool. The tool helps our doctors and other clinicians focus more on their patients and spend less time on administrative tasks. The tool summarizes medical conversations and creates draft clinical notes. Our doctors and clinicians can use the tool during patient visits. Afterward, the doctor or clinician reviews and edits the notes before entering them into the patient’s electronic health record. In deploying the tool, named Abridge, we carefully applied each of our principles of responsible AI. For example: The tool is compliant with state and federal privacy laws. It encrypts patients’ data to protect their privacy. We also get consent from each patient before using the tool. If a patient doesn’t want us to use it, we don’t. We require our doctors and other clinicians to review and edit any clinical notes drafted by the tool. Our patients can trust that AI does not make medical decisions at Kaiser Permanente. Our doctors and other clinicians do. Before making the tool widely available at Kaiser Permanente, we conducted a rigorous quality assurance process. We made sure it worked for all patients, including our non-English-speaking patients. And we continue to collect feedback from our patients and clinicians about their experiences with the tool. How policymakers can help As we work to make sure AI is used responsibly, policymakers can help by: Supporting the launch of large-scale clinical trials. Health care organizations need more robust evidence to evaluate the safety and effectiveness of AI tools. This evidence is critical to building public trust. Establishing systems to monitor AI tools used in clinical care. Monitoring systems would allow health care organizations to learn from each other’s experiences. We could share performance data, safety risks, and best practices. Supporting independent quality assurance testing of AI algorithms. Policymakers and regulators should work with health care organizations to create a nationwide health AI assurance lab network to test health AI performance. AI developers could then test their algorithms on diverse datasets and help demonstrate the safety and effectiveness of AI tools across populations and geographies. Many other industries rely on similar forms of independent testing. For example, the consumer electronics and automotive industries do this kind of testing. The testing wouldn’t replace our own validation of AI tools. It would complement it. To realize AI’s full potential, we and all health care organizations must use it responsibly. At Kaiser Permanente, we’re diligently following our AI principles. And we’re working closely with policy leaders to support industrywide efforts.
Early prostate cancer detection helps one patient fight back

Early prostate cancer detection helps one patient fight back

August 21, 2024
A gap often exists between emerging technologies and their implementation. New technologies can improve our lives. But they can also change our lives. These changes may initially cause fear and anxiety. Emerging technology is especially complicated in health care. There are so many factors to consider, including patient preferences and federal regulations. At Kaiser Permanente, it’s our job to navigate these issues as we consider how new technologies might help us provide better care for our patients. Artificial intelligence is no exception. We believe our clinicians and care teams can use AI to improve health outcomes for our members and the communities we serve. But we also know that nothing slows down the adoption of new technologies more than lack of trust — or worse, technologies that can lead to patient harm. That’s why we use a responsible AI approach. This means we adopt AI tools and solutions only after we thoroughly assess them for excellence in quality, safety, reliability, and equity. With a focus on building trust, we use AI only when it advances our core mission of delivering high-quality, affordable health care services. Our principles for assessing responsible use So how do we assess and deploy AI tools to make sure they meet our standards? We start with privacy. AI tools require a vast amount of data. Ongoing monitoring, quality control, and safeguarding are necessary to protect the safety and privacy of our members and patients. We continually assess for reliability. What works today may not work a few years down the road as technology, care delivery, and patient preferences evolve. We choose AI tools that will work for the long term. We focus on outcomes. If an AI tool doesn’t advance high-quality and affordable care, we don’t use it. We strive to deploy tools transparently. We make patients aware of and ask for consent to our use of AI tools whenever appropriate. For our employees who use AI, we provide explanations of how our AI tools were developed, how they work, and what their limitations are. We promote equity. People and algorithms (the instructions that AI tools follow) alike can contribute to bias in AI tools. Our AI tools are built to minimize bias. We also know AI has the potential to harness large amounts of data and to help identify and address the root causes of health inequities. So, we are also focused on that potential. We design tools for our customers — in the case of AI, our customers are our members, doctors, and employees who will use the tools. Tools must prioritize their needs and preferences. We build trust. We know there’s uncertainty about the effectiveness of AI. We choose tools that offer excellence in safety and performance, and alignment with industry standards and leading practices. We further build confidence by continually monitoring the tools we use. We continue to invest in research that rigorously evaluates the impact of AI in clinical settings. Our principles in action: Assisted clinical documentation One example of how we’ve applied these principles is with our use of an assisted clinical documentation tool. The tool helps our doctors and other clinicians focus more on their patients and spend less time on administrative tasks. The tool summarizes medical conversations and creates draft clinical notes. Our doctors and clinicians can use the tool during patient visits. Afterward, the doctor or clinician reviews and edits the notes before entering them into the patient’s electronic health record. In deploying the tool, named Abridge, we carefully applied each of our principles of responsible AI. For example: The tool is compliant with state and federal privacy laws. It encrypts patients’ data to protect their privacy. We also get consent from each patient before using the tool. If a patient doesn’t want us to use it, we don’t. We require our doctors and other clinicians to review and edit any clinical notes drafted by the tool. Our patients can trust that AI does not make medical decisions at Kaiser Permanente. Our doctors and other clinicians do. Before making the tool widely available at Kaiser Permanente, we conducted a rigorous quality assurance process. We made sure it worked for all patients, including our non-English-speaking patients. And we continue to collect feedback from our patients and clinicians about their experiences with the tool. How policymakers can help As we work to make sure AI is used responsibly, policymakers can help by: Supporting the launch of large-scale clinical trials. Health care organizations need more robust evidence to evaluate the safety and effectiveness of AI tools. This evidence is critical to building public trust. Establishing systems to monitor AI tools used in clinical care. Monitoring systems would allow health care organizations to learn from each other’s experiences. We could share performance data, safety risks, and best practices. Supporting independent quality assurance testing of AI algorithms. Policymakers and regulators should work with health care organizations to create a nationwide health AI assurance lab network to test health AI performance. AI developers could then test their algorithms on diverse datasets and help demonstrate the safety and effectiveness of AI tools across populations and geographies. Many other industries rely on similar forms of independent testing. For example, the consumer electronics and automotive industries do this kind of testing. The testing wouldn’t replace our own validation of AI tools. It would complement it. To realize AI’s full potential, we and all health care organizations must use it responsibly. At Kaiser Permanente, we’re diligently following our AI principles. And we’re working closely with policy leaders to support industrywide efforts.
Our Olympia Medical Center with a three-peat, wins silver

Our Olympia Medical Center with a three-peat, wins silver

August 21, 2024
A gap often exists between emerging technologies and their implementation. New technologies can improve our lives. But they can also change our lives. These changes may initially cause fear and anxiety. Emerging technology is especially complicated in health care. There are so many factors to consider, including patient preferences and federal regulations. At Kaiser Permanente, it’s our job to navigate these issues as we consider how new technologies might help us provide better care for our patients. Artificial intelligence is no exception. We believe our clinicians and care teams can use AI to improve health outcomes for our members and the communities we serve. But we also know that nothing slows down the adoption of new technologies more than lack of trust — or worse, technologies that can lead to patient harm. That’s why we use a responsible AI approach. This means we adopt AI tools and solutions only after we thoroughly assess them for excellence in quality, safety, reliability, and equity. With a focus on building trust, we use AI only when it advances our core mission of delivering high-quality, affordable health care services. Our principles for assessing responsible use So how do we assess and deploy AI tools to make sure they meet our standards? We start with privacy. AI tools require a vast amount of data. Ongoing monitoring, quality control, and safeguarding are necessary to protect the safety and privacy of our members and patients. We continually assess for reliability. What works today may not work a few years down the road as technology, care delivery, and patient preferences evolve. We choose AI tools that will work for the long term. We focus on outcomes. If an AI tool doesn’t advance high-quality and affordable care, we don’t use it. We strive to deploy tools transparently. We make patients aware of and ask for consent to our use of AI tools whenever appropriate. For our employees who use AI, we provide explanations of how our AI tools were developed, how they work, and what their limitations are. We promote equity. People and algorithms (the instructions that AI tools follow) alike can contribute to bias in AI tools. Our AI tools are built to minimize bias. We also know AI has the potential to harness large amounts of data and to help identify and address the root causes of health inequities. So, we are also focused on that potential. We design tools for our customers — in the case of AI, our customers are our members, doctors, and employees who will use the tools. Tools must prioritize their needs and preferences. We build trust. We know there’s uncertainty about the effectiveness of AI. We choose tools that offer excellence in safety and performance, and alignment with industry standards and leading practices. We further build confidence by continually monitoring the tools we use. We continue to invest in research that rigorously evaluates the impact of AI in clinical settings. Our principles in action: Assisted clinical documentation One example of how we’ve applied these principles is with our use of an assisted clinical documentation tool. The tool helps our doctors and other clinicians focus more on their patients and spend less time on administrative tasks. The tool summarizes medical conversations and creates draft clinical notes. Our doctors and clinicians can use the tool during patient visits. Afterward, the doctor or clinician reviews and edits the notes before entering them into the patient’s electronic health record. In deploying the tool, named Abridge, we carefully applied each of our principles of responsible AI. For example: The tool is compliant with state and federal privacy laws. It encrypts patients’ data to protect their privacy. We also get consent from each patient before using the tool. If a patient doesn’t want us to use it, we don’t. We require our doctors and other clinicians to review and edit any clinical notes drafted by the tool. Our patients can trust that AI does not make medical decisions at Kaiser Permanente. Our doctors and other clinicians do. Before making the tool widely available at Kaiser Permanente, we conducted a rigorous quality assurance process. We made sure it worked for all patients, including our non-English-speaking patients. And we continue to collect feedback from our patients and clinicians about their experiences with the tool. How policymakers can help As we work to make sure AI is used responsibly, policymakers can help by: Supporting the launch of large-scale clinical trials. Health care organizations need more robust evidence to evaluate the safety and effectiveness of AI tools. This evidence is critical to building public trust. Establishing systems to monitor AI tools used in clinical care. Monitoring systems would allow health care organizations to learn from each other’s experiences. We could share performance data, safety risks, and best practices. Supporting independent quality assurance testing of AI algorithms. Policymakers and regulators should work with health care organizations to create a nationwide health AI assurance lab network to test health AI performance. AI developers could then test their algorithms on diverse datasets and help demonstrate the safety and effectiveness of AI tools across populations and geographies. Many other industries rely on similar forms of independent testing. For example, the consumer electronics and automotive industries do this kind of testing. The testing wouldn’t replace our own validation of AI tools. It would complement it. To realize AI’s full potential, we and all health care organizations must use it responsibly. At Kaiser Permanente, we’re diligently following our AI principles. And we’re working closely with policy leaders to support industrywide efforts.
Kaiser Foundation Health Plan and Hospitals Q2 2024 financial update

Kaiser Foundation Health Plan and Hospitals Q2 2024 financial update

August 21, 2024
A gap often exists between emerging technologies and their implementation. New technologies can improve our lives. But they can also change our lives. These changes may initially cause fear and anxiety. Emerging technology is especially complicated in health care. There are so many factors to consider, including patient preferences and federal regulations. At Kaiser Permanente, it’s our job to navigate these issues as we consider how new technologies might help us provide better care for our patients. Artificial intelligence is no exception. We believe our clinicians and care teams can use AI to improve health outcomes for our members and the communities we serve. But we also know that nothing slows down the adoption of new technologies more than lack of trust — or worse, technologies that can lead to patient harm. That’s why we use a responsible AI approach. This means we adopt AI tools and solutions only after we thoroughly assess them for excellence in quality, safety, reliability, and equity. With a focus on building trust, we use AI only when it advances our core mission of delivering high-quality, affordable health care services. Our principles for assessing responsible use So how do we assess and deploy AI tools to make sure they meet our standards? We start with privacy. AI tools require a vast amount of data. Ongoing monitoring, quality control, and safeguarding are necessary to protect the safety and privacy of our members and patients. We continually assess for reliability. What works today may not work a few years down the road as technology, care delivery, and patient preferences evolve. We choose AI tools that will work for the long term. We focus on outcomes. If an AI tool doesn’t advance high-quality and affordable care, we don’t use it. We strive to deploy tools transparently. We make patients aware of and ask for consent to our use of AI tools whenever appropriate. For our employees who use AI, we provide explanations of how our AI tools were developed, how they work, and what their limitations are. We promote equity. People and algorithms (the instructions that AI tools follow) alike can contribute to bias in AI tools. Our AI tools are built to minimize bias. We also know AI has the potential to harness large amounts of data and to help identify and address the root causes of health inequities. So, we are also focused on that potential. We design tools for our customers — in the case of AI, our customers are our members, doctors, and employees who will use the tools. Tools must prioritize their needs and preferences. We build trust. We know there’s uncertainty about the effectiveness of AI. We choose tools that offer excellence in safety and performance, and alignment with industry standards and leading practices. We further build confidence by continually monitoring the tools we use. We continue to invest in research that rigorously evaluates the impact of AI in clinical settings. Our principles in action: Assisted clinical documentation One example of how we’ve applied these principles is with our use of an assisted clinical documentation tool. The tool helps our doctors and other clinicians focus more on their patients and spend less time on administrative tasks. The tool summarizes medical conversations and creates draft clinical notes. Our doctors and clinicians can use the tool during patient visits. Afterward, the doctor or clinician reviews and edits the notes before entering them into the patient’s electronic health record. In deploying the tool, named Abridge, we carefully applied each of our principles of responsible AI. For example: The tool is compliant with state and federal privacy laws. It encrypts patients’ data to protect their privacy. We also get consent from each patient before using the tool. If a patient doesn’t want us to use it, we don’t. We require our doctors and other clinicians to review and edit any clinical notes drafted by the tool. Our patients can trust that AI does not make medical decisions at Kaiser Permanente. Our doctors and other clinicians do. Before making the tool widely available at Kaiser Permanente, we conducted a rigorous quality assurance process. We made sure it worked for all patients, including our non-English-speaking patients. And we continue to collect feedback from our patients and clinicians about their experiences with the tool. How policymakers can help As we work to make sure AI is used responsibly, policymakers can help by: Supporting the launch of large-scale clinical trials. Health care organizations need more robust evidence to evaluate the safety and effectiveness of AI tools. This evidence is critical to building public trust. Establishing systems to monitor AI tools used in clinical care. Monitoring systems would allow health care organizations to learn from each other’s experiences. We could share performance data, safety risks, and best practices. Supporting independent quality assurance testing of AI algorithms. Policymakers and regulators should work with health care organizations to create a nationwide health AI assurance lab network to test health AI performance. AI developers could then test their algorithms on diverse datasets and help demonstrate the safety and effectiveness of AI tools across populations and geographies. Many other industries rely on similar forms of independent testing. For example, the consumer electronics and automotive industries do this kind of testing. The testing wouldn’t replace our own validation of AI tools. It would complement it. To realize AI’s full potential, we and all health care organizations must use it responsibly. At Kaiser Permanente, we’re diligently following our AI principles. And we’re working closely with policy leaders to support industrywide efforts.
For a father with prostate cancer, knowledge is power

For a father with prostate cancer, knowledge is power

August 21, 2024
A gap often exists between emerging technologies and their implementation. New technologies can improve our lives. But they can also change our lives. These changes may initially cause fear and anxiety. Emerging technology is especially complicated in health care. There are so many factors to consider, including patient preferences and federal regulations. At Kaiser Permanente, it’s our job to navigate these issues as we consider how new technologies might help us provide better care for our patients. Artificial intelligence is no exception. We believe our clinicians and care teams can use AI to improve health outcomes for our members and the communities we serve. But we also know that nothing slows down the adoption of new technologies more than lack of trust — or worse, technologies that can lead to patient harm. That’s why we use a responsible AI approach. This means we adopt AI tools and solutions only after we thoroughly assess them for excellence in quality, safety, reliability, and equity. With a focus on building trust, we use AI only when it advances our core mission of delivering high-quality, affordable health care services. Our principles for assessing responsible use So how do we assess and deploy AI tools to make sure they meet our standards? We start with privacy. AI tools require a vast amount of data. Ongoing monitoring, quality control, and safeguarding are necessary to protect the safety and privacy of our members and patients. We continually assess for reliability. What works today may not work a few years down the road as technology, care delivery, and patient preferences evolve. We choose AI tools that will work for the long term. We focus on outcomes. If an AI tool doesn’t advance high-quality and affordable care, we don’t use it. We strive to deploy tools transparently. We make patients aware of and ask for consent to our use of AI tools whenever appropriate. For our employees who use AI, we provide explanations of how our AI tools were developed, how they work, and what their limitations are. We promote equity. People and algorithms (the instructions that AI tools follow) alike can contribute to bias in AI tools. Our AI tools are built to minimize bias. We also know AI has the potential to harness large amounts of data and to help identify and address the root causes of health inequities. So, we are also focused on that potential. We design tools for our customers — in the case of AI, our customers are our members, doctors, and employees who will use the tools. Tools must prioritize their needs and preferences. We build trust. We know there’s uncertainty about the effectiveness of AI. We choose tools that offer excellence in safety and performance, and alignment with industry standards and leading practices. We further build confidence by continually monitoring the tools we use. We continue to invest in research that rigorously evaluates the impact of AI in clinical settings. Our principles in action: Assisted clinical documentation One example of how we’ve applied these principles is with our use of an assisted clinical documentation tool. The tool helps our doctors and other clinicians focus more on their patients and spend less time on administrative tasks. The tool summarizes medical conversations and creates draft clinical notes. Our doctors and clinicians can use the tool during patient visits. Afterward, the doctor or clinician reviews and edits the notes before entering them into the patient’s electronic health record. In deploying the tool, named Abridge, we carefully applied each of our principles of responsible AI. For example: The tool is compliant with state and federal privacy laws. It encrypts patients’ data to protect their privacy. We also get consent from each patient before using the tool. If a patient doesn’t want us to use it, we don’t. We require our doctors and other clinicians to review and edit any clinical notes drafted by the tool. Our patients can trust that AI does not make medical decisions at Kaiser Permanente. Our doctors and other clinicians do. Before making the tool widely available at Kaiser Permanente, we conducted a rigorous quality assurance process. We made sure it worked for all patients, including our non-English-speaking patients. And we continue to collect feedback from our patients and clinicians about their experiences with the tool. How policymakers can help As we work to make sure AI is used responsibly, policymakers can help by: Supporting the launch of large-scale clinical trials. Health care organizations need more robust evidence to evaluate the safety and effectiveness of AI tools. This evidence is critical to building public trust. Establishing systems to monitor AI tools used in clinical care. Monitoring systems would allow health care organizations to learn from each other’s experiences. We could share performance data, safety risks, and best practices. Supporting independent quality assurance testing of AI algorithms. Policymakers and regulators should work with health care organizations to create a nationwide health AI assurance lab network to test health AI performance. AI developers could then test their algorithms on diverse datasets and help demonstrate the safety and effectiveness of AI tools across populations and geographies. Many other industries rely on similar forms of independent testing. For example, the consumer electronics and automotive industries do this kind of testing. The testing wouldn’t replace our own validation of AI tools. It would complement it. To realize AI’s full potential, we and all health care organizations must use it responsibly. At Kaiser Permanente, we’re diligently following our AI principles. And we’re working closely with policy leaders to support industrywide efforts.
Kaiser Permanente improves member experience with AI-enabled clinical technology

Kaiser Permanente improves member experience with AI-enabled clinical technology

August 21, 2024
A gap often exists between emerging technologies and their implementation. New technologies can improve our lives. But they can also change our lives. These changes may initially cause fear and anxiety. Emerging technology is especially complicated in health care. There are so many factors to consider, including patient preferences and federal regulations. At Kaiser Permanente, it’s our job to navigate these issues as we consider how new technologies might help us provide better care for our patients. Artificial intelligence is no exception. We believe our clinicians and care teams can use AI to improve health outcomes for our members and the communities we serve. But we also know that nothing slows down the adoption of new technologies more than lack of trust — or worse, technologies that can lead to patient harm. That’s why we use a responsible AI approach. This means we adopt AI tools and solutions only after we thoroughly assess them for excellence in quality, safety, reliability, and equity. With a focus on building trust, we use AI only when it advances our core mission of delivering high-quality, affordable health care services. Our principles for assessing responsible use So how do we assess and deploy AI tools to make sure they meet our standards? We start with privacy. AI tools require a vast amount of data. Ongoing monitoring, quality control, and safeguarding are necessary to protect the safety and privacy of our members and patients. We continually assess for reliability. What works today may not work a few years down the road as technology, care delivery, and patient preferences evolve. We choose AI tools that will work for the long term. We focus on outcomes. If an AI tool doesn’t advance high-quality and affordable care, we don’t use it. We strive to deploy tools transparently. We make patients aware of and ask for consent to our use of AI tools whenever appropriate. For our employees who use AI, we provide explanations of how our AI tools were developed, how they work, and what their limitations are. We promote equity. People and algorithms (the instructions that AI tools follow) alike can contribute to bias in AI tools. Our AI tools are built to minimize bias. We also know AI has the potential to harness large amounts of data and to help identify and address the root causes of health inequities. So, we are also focused on that potential. We design tools for our customers — in the case of AI, our customers are our members, doctors, and employees who will use the tools. Tools must prioritize their needs and preferences. We build trust. We know there’s uncertainty about the effectiveness of AI. We choose tools that offer excellence in safety and performance, and alignment with industry standards and leading practices. We further build confidence by continually monitoring the tools we use. We continue to invest in research that rigorously evaluates the impact of AI in clinical settings. Our principles in action: Assisted clinical documentation One example of how we’ve applied these principles is with our use of an assisted clinical documentation tool. The tool helps our doctors and other clinicians focus more on their patients and spend less time on administrative tasks. The tool summarizes medical conversations and creates draft clinical notes. Our doctors and clinicians can use the tool during patient visits. Afterward, the doctor or clinician reviews and edits the notes before entering them into the patient’s electronic health record. In deploying the tool, named Abridge, we carefully applied each of our principles of responsible AI. For example: The tool is compliant with state and federal privacy laws. It encrypts patients’ data to protect their privacy. We also get consent from each patient before using the tool. If a patient doesn’t want us to use it, we don’t. We require our doctors and other clinicians to review and edit any clinical notes drafted by the tool. Our patients can trust that AI does not make medical decisions at Kaiser Permanente. Our doctors and other clinicians do. Before making the tool widely available at Kaiser Permanente, we conducted a rigorous quality assurance process. We made sure it worked for all patients, including our non-English-speaking patients. And we continue to collect feedback from our patients and clinicians about their experiences with the tool. How policymakers can help As we work to make sure AI is used responsibly, policymakers can help by: Supporting the launch of large-scale clinical trials. Health care organizations need more robust evidence to evaluate the safety and effectiveness of AI tools. This evidence is critical to building public trust. Establishing systems to monitor AI tools used in clinical care. Monitoring systems would allow health care organizations to learn from each other’s experiences. We could share performance data, safety risks, and best practices. Supporting independent quality assurance testing of AI algorithms. Policymakers and regulators should work with health care organizations to create a nationwide health AI assurance lab network to test health AI performance. AI developers could then test their algorithms on diverse datasets and help demonstrate the safety and effectiveness of AI tools across populations and geographies. Many other industries rely on similar forms of independent testing. For example, the consumer electronics and automotive industries do this kind of testing. The testing wouldn’t replace our own validation of AI tools. It would complement it. To realize AI’s full potential, we and all health care organizations must use it responsibly. At Kaiser Permanente, we’re diligently following our AI principles. And we’re working closely with policy leaders to support industrywide efforts.

Sign Up to receive the latest Updates and News

+91 7290972372
H.No. 72 G/F, Near Spa Hostel, NF Colony, Taimoor Nagar, New Delhi 110065, India
[email protected]
Follow our social media

Useful Links

Categories

Newest Listings​

Heart Valve Replacement
Heart Valve Replacement
Dr Vineesh Mathur
Dr Vineesh Mathur
Dr Arvinder Singh Soin
Dr Arvinder Singh Soin
© 2024 Medestan Healthcare Private Limited. All rights reserved.